151 related articles for article (PubMed ID: 8682619)
1. Pathogenic role of Epstein-Barr virus in human cancer.
Takada K; Shimizu N; Tanabe-Tochikura A; Kuroiwa Y
Intervirology; 1995; 38(3-4):214-20. PubMed ID: 8682619
[TBL] [Abstract][Full Text] [Related]
2. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV.
Shimizu N; Tanabe-Tochikura A; Kuroiwa Y; Takada K
J Virol; 1994 Sep; 68(9):6069-73. PubMed ID: 8057484
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata.
Komano J; Sugiura M; Takada K
J Virol; 1998 Nov; 72(11):9150-6. PubMed ID: 9765461
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma.
Shah KM; Young LS
Clin Microbiol Infect; 2009 Nov; 15(11):982-8. PubMed ID: 19874382
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus (EBV) and human disease: facts, opinions and problems.
Griffin BE
Mutat Res; 2000 Apr; 462(2-3):395-405. PubMed ID: 11523539
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus: 40 years on.
Young LS; Rickinson AB
Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
[TBL] [Abstract][Full Text] [Related]
8. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence.
Bakkalci D; Jia Y; Winter JR; Lewis JE; Taylor GS; Stagg HR
J Glob Health; 2020 Jun; 10(1):010405. PubMed ID: 32257153
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis.
Ruf IK; Rhyne PW; Yang C; Cleveland JL; Sample JT
J Virol; 2000 Nov; 74(21):10223-8. PubMed ID: 11024153
[TBL] [Abstract][Full Text] [Related]
11. Contrasting effects of hydroxyurea on cell growth and reduction in Epstein-Barr virus genomes in EBV-infected epithelioid cell lines vs Burkitt's lymphoma cell lines.
Jiang R; Kanamori M; Satoh Y; Fukuda M; Ikuta K; Murakami M; Sairenji T
J Med Virol; 2003 Jun; 70(2):244-52. PubMed ID: 12696111
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction.
Kitagawa N; Goto M; Kurozumi K; Maruo S; Fukayama M; Naoe T; Yasukawa M; Hino K; Suzuki T; Todo S; Takada K
EMBO J; 2000 Dec; 19(24):6742-50. PubMed ID: 11118209
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
De Leo A; Arena G; Stecca C; Raciti M; Mattia E
Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
[TBL] [Abstract][Full Text] [Related]
14. The ecology and pathology of Epstein-Barr virus.
Schmidt CW; Misko IS
Immunol Cell Biol; 1995 Dec; 73(6):489-504. PubMed ID: 8713470
[TBL] [Abstract][Full Text] [Related]
15. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata.
Komano J; Maruo S; Kurozumi K; Oda T; Takada K
J Virol; 1999 Dec; 73(12):9827-31. PubMed ID: 10559294
[TBL] [Abstract][Full Text] [Related]
17. Estimating the global burden of Epstein-Barr virus-related cancers.
Wong Y; Meehan MT; Burrows SR; Doolan DL; Miles JJ
J Cancer Res Clin Oncol; 2022 Jan; 148(1):31-46. PubMed ID: 34705104
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of the polyamine regulator spermidine/spermine N(1)-acetyltransferase by Epstein-Barr virus in a Burkitt's lymphoma cell line.
Shi M; Gan YJ; Davis TO; Scott RS
Virus Res; 2013 Oct; 177(1):11-21. PubMed ID: 23891576
[TBL] [Abstract][Full Text] [Related]
19. Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma.
Ruf IK; Rhyne PW; Yang H; Borza CM; Hutt-Fletcher LM; Cleveland JL; Sample JT
Mol Cell Biol; 1999 Mar; 19(3):1651-60. PubMed ID: 10022853
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus and cancers of the head and neck.
Goldenberg D; Golz A; Netzer A; Rosenblatt E; Rachmiel A; Goldenberg RF; Joachims HZ
Am J Otolaryngol; 2001; 22(3):197-205. PubMed ID: 11351290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
